Chinese Brain Chip Project Accelerates Human Trials, Challenging Global Competitors

Chinese Brain Chip Project Gains Momentum

The Beijing-based Chinese Institute for Brain Research (CIBR) and NeuCyber NeuroTech have announced ambitious plans to accelerate their brain-computer interface (BCI) project, aiming to implant their Beinao No.1 chip into 13 patients by the end of 2025. This development could potentially position China at the forefront of BCI technology, challenging global competitors like Elon Musk's Neuralink 1

1

2

Current Progress and Future Plans

CIBR and NeuCyber have already successfully implanted their semi-invasive wireless brain chip, Beinao No.1, into three patients over the past month. The project has plans for ten more implants this year, with even more ambitious goals on the horizon. Luo Minmin, director of CIBR and NeuCyber's chief scientist, revealed plans for formal clinical trials involving approximately 50 patients in 2026, pending regulatory approval 1

1

3

Global Competition in BCI Technology

The accelerated pace of human trials by the Chinese team could potentially make Beinao No.1 the brain chip with the highest number of patients worldwide. This development underscores China's determination to catch up with and potentially surpass leading foreign BCI developers 1

1

2

Currently, the U.S. company Synchron leads in human trials with 10 patients across the United States and Australia. Elon Musk's Neuralink has reported three successful implants to date. The Chinese project's rapid progress suggests a shifting landscape in the global race for BCI supremacy 1

1

2

3

Technological Approaches and Applications

While Neuralink focuses on wireless brain chips inserted directly into the brain for maximum signal quality, CIBR and NeuCyber, along with other competitors, are developing semi-invasive chips placed on the brain's surface. This approach sacrifices some signal quality but reduces the risk of brain tissue damage and post-surgery complications 1

1

3

Recent demonstrations of the Beinao No.1 chip have shown promising results. Patients with paralysis were able to control robotic arms to perform tasks like pouring water, and even transmit their thoughts onto computer screens 1

1

2

Related Stories

China targets widespread brain-computer interface adoption within 3-5 years as BCI tech race heats up

Paradromics Joins the Race in Brain-Computer Interface Technology with Successful Human Implant

Precision Neuroscience Raises $102 Million, Challenging Neuralink in Brain-Computer Interface Race

Neuralink's Second Brain Implant Patient Plays Video Games with Mind Control

Future Developments and Challenges

CIBR and NeuCyber are not resting on their laurels. They are currently developing Beinao No.2, a wireless version similar to Neuralink's product, with human trials expected within the next 12 to 18 months 1

1

3

However, the path forward is not without challenges. Luo emphasized that while there is significant interest from potential investors, partners need to be "forward-looking" and not focused on immediate profits. The commercial applications of BCI technology remain limited in the short term 1

1

3

Implications and Ethical Considerations

As BCI technology advances, it raises important questions about data privacy, especially in the context of state involvement. There are concerns about how collected data might be used, particularly in countries with different approaches to individual privacy 2

2

The rapid progress of China's BCI projects also highlights the country's growing influence in key technological industries. This development could have far-reaching implications for global technological leadership and the spread of different values and influences around the world 2

2